Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Corporate VCs Do More than Their Fair Share of Private Biotech Financing

This article was originally published in Start Up

Executive Summary

Although venture capitalists have cut back the amount of money they invested in private biotechs during the 2001-2003 timeframe, corporate VCs bucked the trend and continued to participate consistently in supporting these firms with equity investments.

Related Content

Abbott Ventures: Extending Horizons in Abbott's Device Pipeline
Abbott Ventures: Building A Venture Portfolio in Devices
Novartis' Competing Venture Funds Pursue Lower-Cost Innovation


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts